Insider · CIK 0001748010
Michael Stewart Lee
director
Files at FATE (FATE THERAPEUTICS INC), IGMS (IGM Biosciences, Inc.), STTK (Shattuck Labs, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | IGMS IGM Biosciences, Inc. | DDisposition to issuer Common Stock | -12,712 | - | - | 0 | Aug 14, 2025 |
| Jul 14, 2025 | STTK Shattuck Labs, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +33,150 | $0.00 | $0 | 33,150 | Jul 16, 2025 |
| Jun 30, 2025 | IGMS IGM Biosciences, Inc. | AGrant or award Common Stock | +828 | $0.00 | $0 | 12,712 | Jul 2, 2025 |
| May 29, 2025 | FATE FATE THERAPEUTICS INC | AGrant or award Stock Option (Right to Buy)derivative | +55,000 | $0.00 | $0 | 55,000 | May 30, 2025 |
| Mar 31, 2025 | IGMS IGM Biosciences, Inc. | AGrant or award Common Stock | +828 | $0.00 | $0 | 11,884 | Apr 2, 2025 |
| Dec 31, 2024 | IGMS IGM Biosciences, Inc. | AGrant or award Common Stock | +1,734 | $0.00 | $0 | 11,056 | Jan 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.